An elegant gene expression profiling study by Seckinger et al. using hundreds of samples from newly diagnosed and relapse refractory MM (RRMM) patients showed that BCMA is universally and specifically expressed in all tested malignant plasma cells [8]. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.